Phase II study of amsacrine in solid tumors: a report of the EORTC early clinical trial-group
- 28 February 1983
- journal article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 19 (2) , 289-293
- https://doi.org/10.1016/0277-5379(83)90429-7
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Phase II evaluation of 4ʼ-(9-acridinylamino)-methanesulfon-m-anisidine (AMSA) in patients with advanced head and neck cancersAmerican Journal of Clinical Oncology, 1982
- Phase II trial of amsacrine (m-AMSA) in advanced ovarian carcinomaEuropean Journal of Cancer and Clinical Oncology, 1982
- m-AMSA: A New Anticancer AgentPublished by Springer Nature ,1980
- DNA-binding characteristics of acridinylmethanesulphonanilide drugs: Comparison with antitumour propertiesPublished by Elsevier ,1976
- The experimental antitumour properties of three congeners of the acridylmethanesulphonanilide (AMSA) seriesPublished by Elsevier ,1974